First Eagle Investment Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-82,123
Closed -$1.03M 412
2023
Q2
$1.03M Sell
82,123
-26,617
-24% -$317K ﹤0.01% 329
2023
Q1
$1.27M Sell
108,740
-69,000
-39% -$880K ﹤0.01% 323
2022
Q4
$1.89M Sell
177,740
-102,500
-37% -$990K 0.01% 273
2022
Q3
$2.72M Buy
+280,240
New +$3.71M 0.01% 167

Other funds holding HCAT

First Eagle Investment Management's HCAT Position: Q3 2023 in Review

First Eagle Investment Management sold out of Health Catalyst (HCAT) in Q3 2023, closing a stake of 82,123 shares — an estimated $1.03M sold.

First Eagle Investment Management first reported a position in HCAT in Q3 2022 and held it in 4 quarters. The position peaked at $2.72M in Q3 2022. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2023.

  • First Eagle Investment Management reported no remaining Health Catalyst position as of Q3 2023 after selling out during the quarter.
  • First Eagle Investment Management sold 82,123 Health Catalyst shares in Q3 2023, an estimated $1.03M.
  • First Eagle Investment Management first reported a position in Health Catalyst in Q3 2022 and held it in 4 quarters.
  • First Eagle Investment Management's Health Catalyst position peaked at $2.72M in Q3 2022.
  • 159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2023.

Based on First Eagle Investment Management's 13F filing for Q3 2023, filed 8 Nov 2023.